Structural and Functional Analyses of the Human Toll-like Receptor 3
ROLE OF GLYCOSYLATION*
- Jingchuan Sun ‡ § 1 ,
- Karen E. Duffy ¶ 1 ,
- C. T. Ranjith-Kumar ∥ ,
- Jin Xiong ‡ 2 ,
- Roberta J. Lamb ¶ ,
- Jon Santos ∥ ,
- Hema Masarapu ∥ ,
- Mark Cunningham ¶ ,
- Andreas Holzenburg ‡ § ∥ ,
- Robert T. Sarisky ¶ ,
- M. Lamine Mbow ¶ 3 and
- Cheng Kao ∥ 4
- Departments of ∥Biochemistry and Biophysics and ‡Biology and the §Microscopy and Imaging Center, Texas A&M University, College Station, Texas 77843 and ¶Discovery Research, Centocor Research and Development, Inc., Radnor, Pennsylvania 19087
- 3 To whom correspondence may be addressed. Fax: 610-889-4623; E-mail: Lmbow{at}cntus.jnj.com. 4 To whom correspondence may be addressed. Fax: 979-845-9274; E-mail: ckao{at}tamu.edu.
Abstract
Toll-like receptors (TLRs) play critical roles in bridging the innate and adaptive immune responses. The human TLR3 recognizes foreign-derived double-stranded RNA and endogenous necrotic cell RNA as ligands. Herein we characterized the contribution of glycosylation to TLR3 structure and function. Exogenous addition of purified extracellular domain of TLR3 (hTLR3 ECD) expressed in human embryonic kidney cells was found to inhibit TLR3-dependent signaling, thus providing a reagent for structural and functional characterization. Approximately 35% of the mass of the hTLR3 ECD was due to posttranslational modification, with N-linked glycosyl groups contributing substantially to the additional mass. Cells treated with tunicamycin, an inhibitor of glycosylation, prevented TLR3-induced NF-κB activation, confirming that N-linked glycosylation is required for bioactivity of this receptor. Further, mutations in two of these predicted glycosylation sites impaired TLR3 signaling without obviously affecting the expression of the protein. Single-particle structures reconstructed from electron microscopy images and two-dimensional crystallization revealed that hTLR3 ECD forms a horseshoe structure similar to the recently elucidated x-ray structure of the protein expressed in insect cells using baculovirus vectors (Choe, J., Kelker, M. S., and Wilson, I. A. (2005) Science 309, 581-585 and Bell, J. K., Botos, I., Hall, P. R., Askins, J., Shiloach, J., Segal, D. M., and Davies, D. R. (2005) Proc. Natl. Acad. Sci. U. S. A. 102, 10976-10980). There are, however, notable differences between the human cell-derived and insect cell-derived structures, including features attributable to glycosylation.
Footnotes
-
↵5 The abbreviations used are: TLR, Toll-like receptor; hTLR, human TLR; ECD, extracellular domain; HEK, human embryonic kidney; FACS, fluorescence-activated cell sorting; mAb, monoclonal antibody; MALDI-TOF, matrix-assisted laser desorption ionization time-of-flight; MFI, mean fluorescence intensity.
-
↵6 C. Kao, data not shown.
-
↵7 C. T. Ranjith-Kumar, unpublished results.
-
↵* The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
-
↵1 Both authors contributed equally to this work.
-
↵2 Supported by the Welch Foundation.
-
- Received September 22, 2005.
- Revision received February 16, 2006.
- The American Society for Biochemistry and Molecular Biology, Inc.











